Cafepharma Today

June 5 2025 - GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
Bispecific cancer drugs, data caveats and funding alarms: 3 takeaways from ASCO
FDA’s Elsa AI is here, and the industry has questions
Merck gains U.S. patent office support in Keytruda dispute
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Chimerix continues to surge after decision to help ailing 7-year-old boy
Marketwatch
Friday, March 14, 2014 - 8:38am
tags:
Chimerix, Brincidofovir
Novo Nordisk - An Opportune Time To Book Profits
Seeking Alpha
Friday, March 14, 2014 - 8:36am
tags:
Novo Nordisk
Biotechs Post Better Returns This Week Before An IPO Tech Wave
Seeking Alpha
Friday, March 14, 2014 - 8:35am
tags:
IPOs, Achaogen, Dipexium Pharmaceuticals, Galmed Pharmaceuticals, Recro Pharma, Aquinox Pharmaceuticals
With FDA Concerns Public, What's Next for These Cholesterol Drugs?
Motley Fool
Thursday, March 13, 2014 - 5:55pm
tags:
FDA, Regeneron, Pfizer, Amgen, PCSK9 inhibitors
FDA Approves Mallinckrodt's Xartemis XR
Yahoo/Zacks.com
Thursday, March 13, 2014 - 5:53pm
tags:
FDA, Mallinckrodt, hydrocodone, Xartemis XR
Johnson & Johnson's Success In Cardiac Ablation
Seeking Alpha
Thursday, March 13, 2014 - 5:47pm
tags:
cardiac ablation, JNJ, devices, Biosense Webster, St. Jude Medical, SmartTouch catheter
Here’s Why Pfizer’s Holding on to Its Celebrex Patent With Both Hands
Wall St Cheat Sheet
Thursday, March 13, 2014 - 5:45pm
tags:
Pfizer, generics, Celebrex, patents
"Close Call" for American Rx Marketers on Medicare Part D
Pharm Exec
Thursday, March 13, 2014 - 11:42am
tags:
Medicare, Medicare Part D, healthcare reform
The Biotech Bubble: Is It or Isn’t It?
Barron's
Thursday, March 13, 2014 - 11:40am
tags:
biotech
Fate Therapeutics' Prohema in Phase II Study
Yahoo/Zacks.com
Thursday, March 13, 2014 - 11:39am
tags:
Prohema, Fate Therapeutics, stem cells
Pfizer's Breakthrough Vaccine Could Be A Victim Of Its Own Success
Forbes
Thursday, March 13, 2014 - 10:59am
tags:
Pfizer, vaccines, Prevnar 13
Orexigen looking for FDA approval in next few months, says Cowen
Yahoo/Fly on the Wall
Thursday, March 13, 2014 - 10:29am
tags:
Orexigen, obesity, Contrave, FDA
FDA chief defend approval of Zogenix's Zohydro 'unique' pain drug
Yahoo/Reuters
Thursday, March 13, 2014 - 10:26am
tags:
FDA, Zohydro, hydrocodone, painkillers
Quest Diagnostics Has An Improved Outlook After Summit Health Acquisition And $600 Million Refinancing
Seeking Alpha
Thursday, March 13, 2014 - 10:25am
tags:
Quest Diagnostics, diagnostics, Summit Health, M&A
Study finds statin therapy results in fewer side effects than placebo
First Word Pharma
Thursday, March 13, 2014 - 10:19am
tags:
statins
Orexigen Therapeutics Reduces Q4 Loss by 34%
Motley Fool
Thursday, March 13, 2014 - 9:44am
tags:
earnings, Orexigen
Top 4 Medical Device Stocks For 2014
Seeking Alpha
Thursday, March 13, 2014 - 8:56am
tags:
devices, Medtronic, General Electric, Siemens, Sanomedics
FDA considering new requirements for off-label use data
Mass Device
Thursday, March 13, 2014 - 8:52am
tags:
FDA, off-label
Circassia Raises $333.5 Million in IPO for Allergy Shot
Bloomberg
Thursday, March 13, 2014 - 8:47am
tags:
Circassia, allergy shots, IPOs, Cat-SPIRE, cat allergy
Achaogen grabs $72M from IPO
Fierce Biotech
Thursday, March 13, 2014 - 8:35am
tags:
antibiotics, IPOs, Achaogen

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.